Chao Ji

23PUBLICATIONS
30CO-AUTHORS
PharmacogenomicsPsychopharmacologyAllergyDisease surveillanceMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Oct 24, 2025
Predictors of Successful Secukinumab Dose Tapering in Moderate-to-Severe Psoriasis: A Retrospective Study.

Jiawen Chen, Zhixun Xiao, Xueting Zeng

|Mar 20, 2025
Proteomic Profiling and Clinical Insights: The Role of MMP9 in Differentiating Psoriasis Vulgaris from Generalized Pustular Psoriasis.

Ting Gong, Jiawen Chen, Zhixun Xiao

|Mar 07, 2025
Risk of serious infection with JAK inhibitors in immune-mediated inflammatory skin diseases: a meta-analysis of randomized clinical trials.

Xinhong Su, Yushan Ou, Shifan Ruan

|Feb 12, 2025
Upadacitinib Dose Reduction Regimen in Elderly Patients with Atopic Dermatitis, Guided by Treat-to-Target Consensus Recommendations.

Zequn Tong, Xueting Zeng, Fuchen Huang

|Oct 28, 2024
Clinical Features of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Induced by Immune Checkpoint Inhibitor versus Non-Immune Checkpoint Inhibitor Drugs in China: A Cross-Sectional Study and Literature Review.

Kun Qin, Ting Gong, Shi-Fan Ruan

|Oct 16, 2024
Spatial proteomics identifies JAKi as treatment for a lethal skin disease.

Thierry M Nordmann, Holly Anderton, Akito Hasegawa

Pageof 4

Frequent Collaborators

2 joint publications

Chengbei Bao

2 joint publications

Shiling Geng

1 joint publications

Wei Zhou

1 joint publications

Wen Chen